Structural basis for the activity of pp60c-srcprotein tyrosine kinase inhibitors

Abstract

Conformational searches on three closely related pp60c‐src protein tyrosine kinase inhibitors of varying potencies were performed to determine a structural basis for their activity. The first was a linear peptide (PDNEYAFFQf), the second its 10‐membered cyclic analogue, and the third a cyclic analogue with a para carboxyphenylalanine in place of one the F residues. A common backbone conformation with an antiparallel β‐sheet‐like geometry capped by similar β‐turns was found for all three peptides, which may be a binding conformation and gives a candidate pharmacophore for further testing. The interaction between some polar side chains and between some of the aromatic rings may be important for maintaining the correct conformation. The differences in potencies of these inhibitors may be attributed to certain thermodynamic and chemical reasons. © 2001 John Wiley & Sons, Inc. Biopolymers 59: 167–179, 2001

Evaluation of New Indole and Bromoindole Derivatives as pp60c‐Src Tyrosine Kinase Inhibitors

“…Src (pp60 c‐Src ) is the product of the src oncogene and the prototype enzyme of the Src family of protein tyrosine kinases (PTKs) (1). Recent studies have provided renewed interest in Src as a molecular target for cancer therapy (2).…”